February 25, 2022
Ichiro Fujikawa, Chairman, Japan Pharmaceutical Traders’ Association The impact of Russia’s Ukraine invasion on the Japanese pharma industry appears to be limited for now, with epirubicin, a cancer drug, being the only API imported from Ukraine according to Japanese regulators’...read more